Zoetis (ZTS) Cost of Revenue (2012 - 2026)

Zoetis (ZTS) has reported Cost of Revenue for 15 consecutive years, with $673.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 1.36% year-over-year to $673.0 million in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 0.71% increase from a year earlier, with the FY2025 full-year figure at $2.7 billion, down 1.95% from the prior year.
• Cost of Revenue was $673.0 million for Q2 2026 at Zoetis, up from $641.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $728.0 million in Q4 2023 and troughed at $569.0 million in Q1 2022.
• A 5-year average of $651.4 million and a median of $648.0 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue climbed 11.49% in 2023 and dropped 3.89% in 2025, its largest moves.
• Over 5 years, Cost of Revenue stood at $653.0 million in 2022, then increased by 11.49% to $728.0 million in 2023, then declined by 2.88% to $707.0 million in 2024, then climbed by 0.71% to $712.0 million in 2025, then retreated by 5.48% to $673.0 million in 2026.
• The last three Cost of Revenue figures came in at $673.0 million (Q2 2026), $641.0 million (Q1 2026), and $712.0 million (Q4 2025), per Business Quant data.